Introduction
Spinal muscular atrophy (SMA) is an inherited neurodegenera tive disease causing progressive deterioration of motor func tions and loss of motor neurons (Azzouz et al., 2004) . After cystic fibrosis, SMA is the most common autosomal recessive disorder in humans with an incidence of 1 in 6,000 and defines the most common genetic cause of infant mortality. SMA is caused by the loss of Survival Motor Neuron (SMN1), a ubiq uitously expressed gene that encodes a key component of the SMN complex, which is essential for snRNP biogenesis. Bio chemical studies established that SMN mediates the accuracy of interactions between RNA binding proteins and their target snRNAs in the cytoplasm Meister et al., 2002; Paushkin et al., 2002; Wan et al., 2005; Battle et al., 2006; Eggert et al., 2006; Zhang et al., 2008) .
The human genome harbors two homologous, nearly identical genes encoding SMN, SMN1, and SMN2. However, under normal conditions, SMN1 accounts for 90% of cellular SMN expression due to a splicing mutation in SMN2 that results in the production of only a small fraction (10%) of fulllength functional SMN (Lefebvre et al., 1997; Wolstencroft et al., 2005) .
Thus, though SMA is caused by mutations that impair SMN1 function, the severity of the disease is modulated by SMN2 copy number, which varies in the human population (McAndrew et al., 1997) . As SMN2 copy number increases, the amount of fulllength SMN protein also increases, rendering loss of SMN1 less pathogenic. Therefore, cellular processes as well as single genes capable of augmenting SMN protein activity may be therapeutically relevant. To identify such processes/ targets and gain insights into fundamental aspects of SMA, several different organisms, including Drosophila, are currently being used to model this disease (Schrank et al., 1997; Miguel Aliaga et al., 1999 Frugier et al., 2000; Hannus et al., 2000; HsiehLi et al., 2000; Monani et al., 2000; Owen et al., 2000; Paushkin et al., 2000; Chan et al., 2003; McWhorter et al., 2003; Rajendra et al., 2007; Chang et al., 2008; Briese et al., 2009; Kong et al., 2009) .
The Drosophila genome encodes a single orthologue of SMN, the Survival motor neuron (Smn) protein, which is ubiq uitously expressed and localizes to nuclear gems (Chan et al., 2003; Liu et al., 2006; Chang et al., 2008) , similar to the distribu tion observed in vertebrates (Monani, 2005) . In Drosophila, Smn S pinal muscular atrophy (SMA), a devastating neuro degenerative disorder characterized by motor neuron loss and muscle atrophy, has been linked to mutations in the Survival Motor Neuron (SMN) gene.
Based on an SMA model we developed in Drosophila, which displays features that are analogous to the human pathology and vertebrate SMA models, we functionally linked the fibroblast growth factor (FGF) signaling pathway to the Drosophila homologue of SMN, Smn. Here, we characterize this relationship and demonstrate that Smn activity regulates the expression of FGF signaling compo nents and thus FGF signaling. Furthermore, we show that alterations in FGF signaling activity are able to modify the neuromuscular junction defects caused by loss of Smn function and that musclespecific activation of FGF is suffi cient to rescue Smnassociated abnormalities.
Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling
results confirm btl as a bona fide modifier of Smn lossoffunction mutations, thereby validating our initial observations. If, as the above analysis of btl implies, FGF signaling can modulate Smn activity, we expect other genetic elements of the FGF pathway to behave as Smn modifiers as well. We chose to examine this relationship in the mesoderm, as the activity of the FGF signaling pathway has been shown to be important for the development and the maintenance of muscles (Shishido et al., 1993; Beiman et al., 1996; Gisselbrecht et al., 1996; Michelson et al., 1998; Vincent et al., 1998; Schulz and Gajewski, 1999; Stathopoulos et al., 2004) . The mesodermspecific how24BGAL4 driver was used to control expression of inducible RNAi trans genes that specifically target either of the two Drosophila FGF receptors, btl or heartless (htl), and a specific FGF signaling effector, stumps. We monitored the effects of these mutations on two additional Smn RNAi strains, UASSmnRNAi C24 (C24) and UASSmnRNAi N4 (N4), which, based on phenotypic analyses and Smn expression levels, are of increasing allelic strength with respect to the FL26B allele (Chang et al., 2008) .
In control experiments, we observe an Smnindependent effect on viability in backgrounds in which Btl, Htl, or Stumps expression were reduced, whereas no effect on viability was ob served upon removal of one copy of sprouty (sty), an inhibitor of the pathway (Fig. 1, B and C) . However, when Smn activity is reduced in each of these backgrounds, a further decrease in via bility is detected (Fig. 1, B and C) . Moreover, loss of function for the FGF pathway antagonist sty suppresses Smninduced le thality (Fig. 1 C) . Based on these observations, we conclude that a genetic link between Smn activity and the FGF signaling cas cade exists in the mesoderm.
Reduction of FGF signaling in muscles causes NMJ defects
Previous analyses established that the vast majority of mutations in genes that altered the viability of Smn lossoffunction muta tions (Chang et al., 2008) were also accompanied by structural defects in the larval NMJ (Chang et al., 2008) . As multiple alleles of several FGF signaling elements modify Smndependent lethal ity, we assessed the significance of this interaction at the third lar val instar NMJ in several different genetic backgrounds.
An initial examination of the distribution of Htl revealed that it is specifically expressed at the NMJ during the third instar (Fig. 2 , A-L; and Fig. S2 ). This expression appears to be primarily in the muscle, as it coincides with the postsynaptic marker Discs Large 1 (Dlg; Fig. 2 B) and does not obviously overlap with the presynaptic marker nc82 (Bruchpilot; Fig. 2 E) . This is corrobo rated by the localization of additional presynaptic markers, Cysteine string protein (Csp; Fig. 2 H) and antihorseradish per oxidase (antiHRP; Fig. 2 K) , which label synaptic vesicles and neuronal membranes, respectively, and appear to be distinct from Htl expression. Together, these data suggest that Htl is predomi nantly postsynaptic, as indeed is Smn.
The presence of the htl ligands, pyramus (pyr) and thisbe (ths) at the NMJ would suggest that Htl is active, but the localization of the ligands has not been previously de scribed. In embryos, it is known that the ligands are expressed in the epithelia adjacent to the mesoderm, which expresses htl lossoffunction mutations result in reduced viability and de creased motility as well as muscular atrophy in the adult thorax, phenotypes analogous to the human pathology (Chan et al., 2003; Rajendra et al., 2007; Chang et al., 2008) . Moreover, neuro muscular junction (NMJ) defects are associated with both verte brate and invertebrate models (Chan et al., 2003; Chang et al., 2008; Kariya et al., 2008) . In addition to its canonical subcellular distribution, Smn is also clearly concentrated in the postsynaptic region of the larval NMJ (Chang et al., 2008) and has been re ported to localize to sarcomeres of adult myofibrils (Rajendra et al., 2007) . Despite this, tissuespecific reduction of Smn dem onstrates that normal NMJ morphology requires Smn activity in both muscles and neurons (Chang et al., 2008) . Finally, an obser vation of critical importance to the Drosophila model is that the morphology and the physiology of the NMJ are sensitive to lev els of Smn (Chang et al., 2008; unpublished data) , mirroring the SMN2 dosage dependence observed in SMA patients.
Taking advantage of the dosage sensitivity of Smn loss offunction phenotypes, we performed systematic genetic screens to identify modifiers of Smn activity (Chang et al., 2008) . Among the genes identified in this manner was the breathless locus, which encodes one of the two Drosophila FGF receptors (Glazer and Shilo, 1991) . In general, the FGF pathway has been dem onstrated to be involved in a diverse range of cellular and de velopmental processes, including proliferation, migration, differentiation, and apoptosis (Itoh and Ornitz, 2004; Huang and Stern, 2005) . In Drosophila, this pathway has been demon strated to control the development of the tracheal system (Ghabrial et al., 2003) and the musculature (Shishido et al., 1993 (Shishido et al., , 1997 Beiman et al., 1996; Gisselbrecht et al., 1996; Michelson et al., 1998; Vincent et al., 1998; Schulz and Gajewski, 1999; Stathopoulos et al., 2004) . In contrast, the role of FGF in the Drosophila nervous system remains poorly characterized (García Alonso et al., 2000; Forni et al., 2004) .
In this study, we investigate the relationship between Smn and several components of the FGF pathway, demonstrating a clear link between Smn and FGF. Epistasis analysis reveals that Smn regulates FGF signaling output, and molecular studies in dicate that Smn activity influences FGF receptor transcript levels. Furthermore, we show that activation of FGF signaling can restore Smnassociated NMJ defects, thus raising the possi bility that FGF can act as a protective modifier of SMA.
Results
The FGF signaling pathway and Smn breathless (btl), which encodes one of the two known Drosophila FGF receptors, was identified in a genetic screen as a modi fier of Smndependent lethality (Chang et al., 2008) , suggesting a connection between the FGF pathway ( Fig. 1 A) and Smn. We extended this finding by determining the effect of different btl mutations on Smndependent viability using an inducible RNAi allele of Smn, UASSmnRNAi FL26B (FL26B), which displays re duced viability when ubiquitously expressed by the tubulinGAL4 (tubGAL4) driver (Chang et al., 2008 , and UAS-btl) as judged by our survival assay (Fig. S1, A and B) . These genetic Linking Smn to FGF signaling • Sen et al.
To corroborate these observations and ensure that the structural defects we observe at the larval NMJ are associated with the FGF pathway, we modulated the activities of htl and its downstream effectors, stumps (dof) and sprouty (sty) using GAL4inducible transgenic strains to determine whether further modifications in FGF signaling result in structural defects at the larval NMJ. Musclespecific expression of sty, a dominant in hibitor of the pathway (how24BGAL4:UAS-sty; Fig. 3 , C and G; and Fig. S3 A) , or a transgenic UAS-htl RNAi construct caused a similar NMJ phenotype (how24BGAL4:UAS-htlRNAi; Fig. 3 G and Fig. S3 A) .
Though overexpression of just htl in muscles had no dis cernable impact on NMJ growth (how24BGAL4:UAS-htl; Fig. 3 G and Fig. S3 A) , expression of stumps, which acts upstream of Ras, caused a pronounced synaptic overgrowth and an overelaboration of synaptic terminals (how24BGAL4:UAS-stumps; Fig. 3 , D and G; and Fig. S3 A) . Quantification of the number of synaptic boutons, (Stathopoulos, et al., 2004) . However, because antibodies that recognize the ligands are not available, we used qPCR to determine that each is expressed to varying degrees in the third instar larva (Fig. 2, M and N) .
Although the above analysis is compatible with the notion that the postsynaptic expression of Htl is functionally relevant, it does not have the resolution necessary to provide reliable evi dence for Htl activity. To explore this possibility directly, we exam ined the NMJs of larvae in which htl activity is reduced through the muscledirected expression of an htl dominantnegative transgenic construct (how24BGAL4/UAS-htl DN ; Michelson et al., 1998) . This manipulation caused significant alterations in the NMJ synaptic terminals (Fig. 3 B) as compared with sibling controls (Fig. 3 A) . The defects were quantified by counting the number of boutons per muscle and normalized to muscle sur face area, revealing a significant (40%) reduction in synaptic size ( Fig. 3 G and Fig. S3 A) . In Drosophila, pathway activation is mediated by the two known FGF receptor orthologues, breathless (btl) and heartless (htl) (Glazer and Shilo, 1991) . btl, which functions in the tracheal system, is activated by its ligand branchless (bnl) (Sutherland et al., 1996) , whereas htl, which functions in the mesoderm and muscles, is activated either by the thisbe (ths) (Kerr et al., 2003) or pyramus (pyr) (Stathopoulos et al., 2004) ligands. Both receptors act through Sos-Grb2 to activate Ras/Raf/MAP kinase signaling. Additional regulation of Ras/Raf/MAP kinase signaling occurs through stumps (Vincent et al., 1998) , which regulates the phosphatase corkscrew (csw) (Petit et al., 2004) . In turn, Csw negatively regulates sprouty (sty), itself a negative regulator of Raf, thereby leading to MAPK activation (Jarvis et al., 2006) . (B) The lethal phenotype associated with mesoderm-specific how24BGAL4-directed expression of UAS- Smn-RNAi C24 is enhanced by the reduction of the FGF signaling pathway components htl, stumps, and breathless. (C) sprouty alleles suppress the how24BGAL4 UAS-Smn-RNAi lethal phenotype. Significant differences are indicated (*, P < 0.05; **, P < 0.01). which reflects synaptic size, revealed that musclespecific stumps overexpression resulted in a 15-20% increase in the number of synaptic boutons at muscle 4 ( Fig. 3 G and Fig. S3 A) and a 35% increase at the muscle 6/7 A3 synapse ( Fig. S4 ) relative to con trols. Though there was a significant effect on NMJ size, there were no gross morphological defects as the localization of pre (antiHRP) and postsynaptic markers (antiDlg) were not detect ably altered, and there was no major variation in muscle size or morphology. Thus, the effects of FGF lossoffunction (Fig. 3, B , C, and G; and Fig. S3 A) are opposite to those observed for FGF gainoffunction (Fig. 3 , D and G; and Fig. S3 A) in the regula tion of synaptic elaboration on muscle 4, a strong genetic argu ment in favor of a functional role for FGF signaling at the NMJ.
In contrast, presynaptic expression of RNAi transgenes for htl and stumps using the elavGAL4 driver did not result in any measurable changes in synaptic size (elavGAL4:UAS-htl or elavGAL4:UAS-stumps; Fig. 3 , E-G; and Fig. S3 A) , suggesting that htl and stumps are not active presynaptically. It is important to point out, however, that we cannot exclude a presynaptic role for these elements of the FGF pathway given the possibility that RNAi in neurons may not have been effective. Despite this caveat, these experiments demonstrate that activation of the FGF path way in the muscle is required to regulate the size of the NMJ.
FGF signaling in muscles affects responsiveness to presynaptic transmitter release
The preceding experiments show that altering FGF components in the muscle influences presynaptic morphology, which is likely accompanied by changes in either transmitter release or post synaptic receptivity. To directly test this possibility, we per formed electrophysiological measurements of evoked excitatory junction potentials (EJPs) under conditions in which we either increased or decreased FGF signaling selectively in the muscle using the how24BGAL4 driver. Perturbation of FGF signaling in muscles primarily leads to altered mEJP (miniature EJP) ampli tude or quantal size (Fig. 4) , a phenotype most often associated with the postsynaptic compartment (Petersen et al., 1997) . Thus, increasing the expression of wildtype Htl decreases the aver age mEJP amplitude by more than 50%, whereas inhibition of FGF signaling through expression of the dominantnegative htl transgene increases mEJP amplitude by 50%. Interestingly, such reciprocal regulation of quantal size by htl is also mirrored in our EJP measurements (Fig. 4 , A and B). As a result, quantal content (defined as the number of synaptic vesicles released per action potential and estimated by dividing the mean EJP re sponse by the mean mEJP amplitude) remains essentially un changed across genotypes. In addition, there are no observed changes in the frequencies of spontaneous release. It is note worthy that changes in EJP and mEJP values are contrary to those observed for presynaptic bouton number, an observation most parsimoniously explained through feedback mechanisms interactions between this pathway and Smn arise from the cumu lative, rather than synergistic, effects of these mutations. If these interactions were due to additive effects, then the introduction of a single recessive allele of either btl or htl would not be expected to significantly alter the NMJ phenotype of Smn mutants. There fore, we assayed whether either a strong hypomorphic allele of btl (btl dev1 ) or a null allele of htl (htl AB42 ) could modify as hetero zygotes the reduction of the NMJ size caused by the muscle specific expression of the UASSmnRNAi C24 allele.
that are known to operate at the larval NMJ to control its struc tural and functional properties (see Discussion). Therefore, the morphological changes associated with FGF signal modulation at the NMJ are accompanied by functional abnormalities.
Synergy of Smn and FGF signaling in muscles regulates NMJ growth
Given that the effects of loss of FGF signaling on NMJ mor phology are independent of Smn, it is possible that the observed Examination of larvae heterozygous for either of the two FGF receptors (how24BGAL4/btl dev1 or how24BGAL4/htl AB42 ) revealed the introduction of these mutations had no significant effect on the NMJ size of animals from the how24BGAL4 driver genetic background (how24BGAL4/+) as assayed by the num ber of synaptic boutons per unit of muscle surface area (MSA; Fig. 5 , A, C, E, and G; and Fig. S3 B) Fig. 5, B , D, and G; and Fig. S3 B) .
Because these results indicate the link between FGF signaling and Smn activity is synergistic rather than additive, we applied a further, more stringent assay to determine the sen sitivity of the NMJ to this interaction. Examination of trans heterozygous larvae carrying a combination of null alleles of Smn and htl (Smn Fig. S3 B) . Thus, this experiment provides formal evidence that the relationship we have uncovered is synergistic in nature and is not merely due to the additive effects of two mutations that independently affect the NMJ.
Activation of FGF signaling in muscles rescues synaptic defects caused by Smn RNAi
Because reduction of FGF signaling clearly exacerbates the NMJ defects caused by Smn loss, we examined whether activa tion of this pathway could reverse these effects. As shown in Fig. 6 , musclespecific overexpression of wildtype Htl com pletely rescues the NMJ phenotypes associated with both the UAS-Smn-RNAi C24 allele and the stronger UAS-Smn-RNAi N4 al lele (Fig. 6 , B-D and G; Fig. S3 C) . In control crosses, expression of Stumps alone resulted in an expansion of synaptic branch ing ( Fig. 6 E) ; however, as observed for Htl, expression of Stumps completely suppressed the NMJ defects observed in the how24BGAL4; UASSmnRNAi C24 background (Fig. 6 F and G; and Fig. S3 C) . These results suggest that Smn is situated upstream of the FGF pathway. Based on this genetic behavior, however, we could not distinguish whether Smn directly regulates htl or any other pathway component.
Smn regulates expression of the FGF receptor, Htl, and its downstream effector Stumps
To further explore the relationship between Smn and FGF signal ing pathway components, we first tested whether reducing Smn expression impacts expression of Htl and Stumps. Using the how24B driver to direct expression of the UASSmnRNAi N4 transgenic construct in the musculature resulted in a drastic post synaptic reduction in Htl levels at the NMJ (Fig. 7, D-F) as well as a more general loss of Stumps staining throughout the muscle (Fig. S5) . Conversely, we did not detect any obvious changes in the distribution or levels of the Smn protein when htl activity was reduced postsynaptically (how24BGAL4/UAS-htl DN ; Fig. 7, G-I ), indicating that FGF activity does not influence Smn expression. These observations corroborate the relationship observed above and indicate that Smn regulates elements of the FGF pathway.
Ideally, the aforementioned observations, which address the issue of autonomy in the Smn-FGF pathway interaction, would have included data derived from classical alleles of Smn. Unfortunately, however, it is practically impossible to generate the motor neuron or muscle mitotic clones necessary to examine this question. For this reason, we extended our ob servations to include the Drosophila wing imaginal disc, a tis sue that is well suited to this type of experiment and where the distribution and expression levels of elements of the FGF pathway have been well characterized (Sato and Kornberg, 2002 ). An additional benefit of analyzing this relationship in the wing disc is that it allows us to determine whether the abil ity of Smn to regulate Htl is not specific for the NMJ but is con served across tissues.
Therefore, we monitored Htl and Stumps expression in Smn lossoffunction mitotic clones that were generated using several different classical alleles of Smn. In these Smn / cells, both Htl and Stumps expression were lost (Fig. 8, A-F) . htl ex pression is unaffected in stumps mutant embryos, and conversely, stumps expression is unaffected in htl mutant embryos (Vincent et al., 1998) , and we thus attribute these observations in the wing imaginal disc to the loss of Smn activity. Together, these results both corroborate and extend our investigation of the epistatic re lationship established between Smn and FGF signaling.
As Smn is required for basic RNA metabolism, removal of its activity might be expected to affect expression of multiple proteins. Therefore, to test the specificity of the molecular rela tionship between Smn and FGF, we monitored the effects of loss of Smn function on the expression of Factin and the transcrip tion factor, Cut, a gene whose expression overlaps that of Htl in the developing wing. Our results indicate that removal of Smn activity had no effect on the distribution or levels of either cyto skeletal actin (Fig. 8, G-I) or Cut (not depicted) in the wing imag inal disc. Consistent with this notion, reduction of Smn at the NMJ had no discernable effect on Dlg expression (Fig. 7, D-F) .
RNAi-induced knockdown of Smn affects htl transcript levels
Having established that reduction of Smn at the NMJ or removal of Smn activity in the wing imaginal disc reduces or eliminates Htl expression, respectively (Fig. 7 D, Fig. 8 B) , indicating that the SMN-FGF relationship is not specific for the NMJ, we were how24BGAL4; UASGFP is used as control. The ANOVA multiple comparison test was used for statistical analysis of the bouton number/muscle. P ≤ 0.05. Bar, 50 µm. n = 40. All preparations were stained with anti-HRP (red) and anti-Dlg (green). The muscle nucleus was labeled using DAPI.
aforementioned genetic background of two independent in sertions of Smn transgenes (UAS-Smn-FLAG B and UAS-Smn-FLAG C ) that partially rescue Smn lethality (Chang et al., 2008) results in slight increases in Smn transcripts. It is noteworthy that, depending on the construct used, we observed signifi cantly different changes in htl levels. Remarkably, expression of UAS-Smn-FLAG C , which led to only a slightly higher increase in Smn levels (27% of wild type) when compared with the interested in exploring the underlying mechanism. Given the role of Smn in snRNP biogenesis, it is possible that reduction of Smn could alter levels of htl transcript, so we tested this using mRNA isolated from third larval instar brains. As shown in Fig. 8 signaling inversely regulates quantal size. Thus, FGF perturba tion in muscle alters both presynaptic growth and specific as pects of synaptic transmission. These observations imply the existence of functional transsynaptic homeostatic mecha nisms, which have been previously shown to compensate for similar changes by increasing presynaptic bouton numbers and transmitter release (Davis et al., 1998; Sigrist et al., 2000 Sigrist et al., , 2002 Menon et al., 2004) . However, in this specific instance, only synaptic growth (bouton number) but not transmitter release (quantal content) is affected, the precise mechanisms for which remain unclear. Moreover, the fact that mEJP amplitudes are affected suggests that postsynaptic receptivity to glutamate release from the presynapse is altered. Similar quantal size phenotypes have been observed in several instances previously. For instance, postsynaptic PKA and NFB are known to regu late quantal size (Davis et al., 1998; Heckscher et al., 2007) through changes in DGluRs. Directly altering the expression of various GluR subunits also predictably influences quantal size (Petersen et al., 1997; Marrus et al., 2004; Featherstone et al., 2005) . The genetic interaction we have demonstrated between FGF and Smn can be described as an epistatic relationship in which the FGF pathway functions downstream of Smn and is consistent with the observation that neuromuscular defects as sociated with loss of Smn function in muscle can be rescued by musclespecific activation of FGF signaling. Intriguingly, the relationship we describe here between Smn and FGF is valid beyond the NMJ, as loss of Smn function genetic mosaics in the wing disc clearly result in the downregulation of FGF signal ing. Although the precise molecular mechanism underlying this relationship is still elusive, Smn activity affects transcript and protein levels of the FGF receptor, as well as the expres sion of additional elements of the FGF pathway. Whether this defines a cascade of interrelated events or whether each of these changes reflects an independent Smnrelated regulatory event remains to be determined. Given the fact that Smn mutants in Drosophila display altered postsynaptic currents and se verely compromised postsynaptic receptor clustering in mus cles (Chan et al., 2003) , it is conceivable that FGF signaling represents a link between Smn activity and postsynaptic gluta mate receptor levels.
Here it should be noted that a link between SMN and the FGF pathway has been suggested by a series of studies in verte brates where a molecular interaction between an FGF2 isoform and the SMN protein has been described (Claus et al., 2003 (Claus et al., , 2004 Bruns et al., 2009) .These studies raise the possibility that FGF2 may negatively interfere with SMN complex function through SMN itself. Such observations would, on first appear ance, suggest that the epistatic relationship between SMN and FGF signaling in vertebrate cells may be the reverse of what we observe in Drosophila. In point of fact however, the differences in the experimental parameters and approaches between these studies do not allow meaningful comparisons.
expression of UAS-Smn-FLAG
B (21% of wild type), fully re stored htl transcript levels to the wildtype value, as opposed to the small rescue effect we see with UAS- Smn-FLAG B . These re sults demonstrate that reduction of Smn activity acts to modu late the levels of htl mRNA. Furthermore, it appears that a small increase in Smn may lead to a large change in the levels of htl, which in turn influence the survival of the animal.
Discussion
Given the variability of the SMA phenotype and the proven re lationship between the severity of the disease and small changes in wildtype SMN activity, there is a significant possibility that any modifiers of SMN activity, either direct or indirect, will have therapeutic value. To systematically explore the genome for genes that are capable of modulating SMN function in vivo, we took advantage of the existence of an SMA model offered by Drosophila to search for Smn genetic interactors (Chang et al., 2008) . The model we developed is based on the lethality and an associated neuromuscular junction phenotype linked to loss of Smn function, a phenotype remarkably similar to the NMJ pheno type reported for human patients (Kariya et al., 2008) . Though the role of SMN in biogenesis of snRNPs has been well docu mented, its regulators and downstream effectors have not been systematically delineated, nor has the link between mutations in SMN and the specific loss of motor neurons seen in SMA pa tients been uncovered. It may be the case that the specificity of this phenotype is reflective of either specialized SMN functions at the NMJ or a particular sensitivity of motor neurons to the loss of SMN activity (McWhorter et al., 2003; Carrel et al., 2006; Kariya et al., 2008; Murray et al., 2008 Murray et al., , 2010 Kong et al., 2009) . Among the genes our genetic strategy revealed as Smn loss of function modifiers was breathless, encoding an FGF re ceptor, thus establishing a link between Smn and the FGF path way (Chang et al., 2008) .
Importantly, in addition to this link, we also found that FGF signaling is independently involved in NMJ morphogenesis, a function demonstrated in vertebrates (Fox et al., 2007) but not previously attributed to this pathway in Drosophila despite exten sive characterization of its essential role in branching morpho genesis of the tracheal system, migration of multiple cell types, as well as the proper patterning of the mesoderm (Shishido et al., 1993 (Shishido et al., , 1997 Beiman et al., 1996; Gisselbrecht et al., 1996; Michelson et al., 1998; Vincent et al., 1998; Schulz and Gajewski, 1999; Ghabrial et al., 2003; Stathopoulos et al., 2004) . The morphological effects we observe, caused by the modulation of several pathway elements, plainly reveal an involvement of FGF signaling at the NMJ, a role confirmed by the electrophysiologi cal analyses. The downregulation of FGF signals in muscle re sults in a reduction of bouton numbers and is associated with increased mEJP amplitudes. The opposite effect is observed when FGF signaling is increased in muscles, suggesting that FGF results in changes in htl transcript levels. The following genotypes are depicted: w 1118 ; tubulinGAL4 (tubGAL4)/+ (columns 1 and 2), w
1118
; (Johns Hopkins University School of Medicine, Baltimore, MD; Cousins et al., 1996; Lee et al., 1996) , Mark Krasnow (Stanford University School of Medicine, Stanford, CA; Sutherland et al., 1996) , and Maria Leptin (European Molecular Biology Laboratory, Heidelberg, Germany; Vincent et al., 1998) 
UAS-SmnRNAi

, respectively. UAS-FLAG-Smn, UAS-Smn-RNAi
C24
, UAS-Smn-RNAi FL26B , and UAS-Smn-RNAi N4 transgenic strains were used to modulate the Smn expression level (Chang et al., 2008) . The actGAL4 (Ito et al., 1997) , elavGAL4 (Luo et al., 1994) , how24B-GAL4, ptcGAL4 (Brand and Perrimon, 1993) , and tubGAL4 (Lee and Luo, 1999) strains were used to drive the genes placed under the UAS promoter.
Viability assay
Three driver GAL4 males were crossed with four UAS transgenic females and cultured on standard fly media overnight. Flies were transferred to fresh media and allowed to lay eggs for 2 d. Adults were subsequently discarded and the progeny were cultured at 25°C. For all crosses, the percentage of viability was calculated as (1) the total number of adults divided by the total number of pupae (defined as Adults); or (2) the total number of dead pupae 4-5 d after puparium formation plus the number of individuals that reached adult stages divided by the total number of pupae (defined as Late Pupal Viability). Viability was calculated based on four independent crosses for each genotype.
Antibody staining NMJ preparation and analysis: third instar larvae were dissected in cold 1x phosphate-buffered saline (PBS) and fixed at room temperature (RT) for 20 min in 4% paraformaldehyde (PFA). The samples were washed in 0.1% Triton X-100 in PBS (PTX) and incubated overnight at 4°C with primary antibody. The primary antibody was washed off with PTX at RT. The samples were incubated at RT with secondary antibody for 90 min. This was followed by PTX wash, and the tissues were mounted in Vectashield mounting media with DAPI (Vector Laboratories). Bouton numbers were counted using a microscope (TE2000; Nikon), based on the Discs large and anti-HRP staining in the A3 segment muscle 4 as indicated. The muscle area for every animal was measured, and no significant difference was observed among different genotypes. At least 20-25 animals of each genotype were dissected for the bouton analysis. The ANOVA multiple comparison test was used for statistical analysis of the bouton number/muscle. The images were pseudo-colored using Adobe Photoshop CS2 (v9.0.2). Wing imaginal disc preparation and analysis: third instar larvae were dissected and fixed as described previously (Kankel et al., 2004) . Discs were stained at RT with the following primary antibodies in PBS Triton X-100 (PBSTx): mouse anti-Smn (Chang et al., 2008) at 1:500; rabbit anti-Htl (Shishido et al., 1997) at 1:3,000; rabbit anti-Stumps (Vincent et al., 1998) at 1:2,000; and mouse anti-Cut (Developmental Studies Hybridoma Bank) at 1:10; and were visualized with Alexa Fluor 488 goat anti-mouse (green) and Alexa Fluor 594 goat anti-rabbit (red), both at 1:1,000 (Invitrogen). Alexa Fluor 594 conjugated to phalloidin was used at 1:100 (Invitrogen). Discs were mounted in Vectashield with DAPI.
Microscopy
All images were collected with a spectral point scanning confocal (model C1si; Nikon) connected to an inverted microscope (TE2000; Nikon) equipped with DIC, phase, and epi-fluorescence optics; 40x Plan Fluor NA 1.4 objective lens; the Perfect Focus System for continuous maintenance of focus; 100-mW mercury arc lamp illumination for viewing fluorescence by eye; and confocal scanning using solid-state diode lasers (Melles Griot): 405 nm, 488 nm (10 mW), and 561 nm (10 mW). The image acquisition software used was Nikon EZ-C1. All samples were mounted and imaged in Vectashield mounting medium with DAPI (Vector Laboratories) at room temperature. Adobe Photoshop CS5 was used to pseudocolor images.
Electrophysiology
Electrophysiological recordings were made from muscle 6 in segment A3 from wandering third instar larvae in modified HL3 saline (0.5 mM Ca 2+ ) as described previously (Stewart et al., 1994; Sanyal et al., 2002; Kim et al., 2009) . In brief, electrodes with tip resistances between 25-30 MΩ were used to record evoked excitatory junction potentials (EJPs) after a stimulus train delivered at 0.5 Hz to the segmental nerve such that both units were consistently recruited. Only recordings where the resting membrane potential was more polarized than 60 mV were selected for analysis. Because EJPs were larger than 10 mV in amplitude, Martin's correction for nonlinear summation was applied to all recordings (McLachlan and Martin, 1981; Kim et al., 2009) . Spontaneous events (mEJPs) were recorded for a total duration of 2 min and were analyzed using MiniAnalysis An important question raised by the above phenotypic analyses is whether the abnormalities associated with FGF and/or Smn perturbations reflect developmental or maintenance issues. It may be the case that the larval system in Drosophila is not ideally suited to differentiate between these alternatives as larval tissue is destined to undergo programmed cell death (his tolysis) during metamorphosis. One advantage that flies do offer, however, is the ability to dissociate the development of the adult neuromuscular system from its maintenance as the en tirety of its development occurs during the pupal stage, before emergence of the adult (Fernandes and Keshishian, 1998; Consoulas et al., 2002; Hebbar and Fernandes, 2004) . Thus, the Drosophila pupa/adult may provide a platform to address these issues, as Drosophila displays Smndependent adult phenotypes (unpublished data; Rajendra et al., 2007) . In light of the rela tionship we established between Smn and FGF signaling and the known involvement of FGF signaling in the development of both the larval and adult musculature Shishido et al., 1993 Shishido et al., , 1997 Vincent et al., 1998; Imam et al., 1999; Schulz and Gajewski, 1999; Stathopoulos et al., 2004; Dutta et al., 2005; Wilson et al., 2005; Kadam et al., 2009 ), it will be particularly interesting to examine the effects of modulat ing FGF activity on the aforementioned processes. Such studies may be of particular relevance to SMA where it is quite difficult to discern the developmental consequences of SMN loss in humans, as neurodegenerative symptoms displayed by patients may obscure basic problems resulting from altered develop mental programs such as neuronal pathfinding, initial NMJ for mation, etc (Simic et al., 2008; Liu et al., 2010) .
In vertebrates, synaptic development and maintenance use at least three distinct signaling mechanisms: the TGF, wingless, and FGF pathways. In Drosophila, it is noteworthy that the first two have been demonstrated to function in a similar fashion at the NMJ (Packard et al., 2002; McCabe et al., 2003) . Re markably, our genetic screens involving Smn have identified el ements of all three of these pathways as modifiers of Smnrelated phenotypes (Chang, et al., 2008; unpublished data) . We con sider these connections particularly significant as they raise the possibility that Smn may serve as a node, integrating signaling events crucial for NMJ function, potentially leaving this struc ture particularly vulnerable to the loss of Smn. Though further correspondence between the Drosophila model and the human condition remains to be determined, the Smn-FGF relationship we observe in Drosophila raises the possibility that pharmaco logical manipulation of FGF signals might mitigate SMN motor neuron-related abnormalities.
Materials and methods
Drosophila stocks and culture All fly stocks were maintained on standard fly medium at 25°C. Submitted: 2 April 2010 Accepted: 10 January 2011 software (Synaptosoft, Inc.). EJPs were low-pass filtered and analyzed in Clampfit and representative images were generated in Microsoft Excel and Adobe Photoshop. Quantal content is determined by dividing the average corrected EJP amplitude by the average mEJP amplitude in each instance. Statistical significance was determined using ANOVA.
Strain construction
Smn FRT 79D-F chromosomes were constructed by recombining the Smn 73Ao (Chan et al., 2003) , Smn f05960 (Thibault et al., 2004) , and Smn X7 (Chang et al., 2008) 
Somatic mitotic clones
Clones of Smn tissue were induced by mitotic recombination using the FLP-FRT technique (Golic, 1991; Xu and Rubin, 1993) . Mutant Smn clones in wing imaginal discs were identified by loss of GFP driven by the ubiquitin reporter (Ubi-GFP). The crosses were as follows: y w hsFLP122; Ubi-GFP FRT 79D-F females were crossed to Smn X7 FRT 79D-F/TM6C, Sb Tb, Smn 73Ao FRT 79D-F/TM6C, Sb Tb and Smn f05960 FRT 79D-F/TM6C, Sb Tb males. Approximately 20 y w hsFLP122; Ubi-GFP FRT 79D-F females were crossed to Smn FRT 79D-F/TM6C, Sb Tb males and allowed to lay eggs for 3 d at 25°C; vials were then heat-shocked at 37°C for 2 h on two consecutive days to induce somatic clones. The somatic clones produced using the Smn X7 allele produced very small Smn somatic clones and were not used for assessing Htl or Stumps expression. Smn expression was not detected in somatic clones generated using the Smn 73Ao allele, suggesting that it behaves as a molecular null. In Smn f05960 somatic clones, Smn levels were strongly reduced, but not eliminated, suggesting that it is hypomorphic in nature. Consistent with this notion, Smn and Stumps expression were reduced, but not eliminated in Smn f05960 somatic clones.
RNA extraction, quality control, and reverse transcription RNA was extracted following standard procedure. In brief, third instar larvae were dissected in ice-cold PBS, and brains and wing imaginal discs (100 brains/sample) were collected into TRIzol (Life Sciences). Samples were homogenized, and RNA was isolated after purification on an RNeasy mini column (QIAGEN). Quality control of RNA was assessed with a Bioanalyzer 2100 (Agilent Technologies) and only high quality samples were chosen for further analysis of gene expression. 200 ng of total RNA were reverse transcribed using the High Capacity RNA-to-cDNA kit (Applied Biosystems) following the manufacturer's instructions.
RT-PCR
The following oligonucleotides were designed for RT-PCR assays: htl sense: 5-CGGAAGGGATCAGGATAGGG-3 and antisense: 5-CCTCG-CCAGTCCAAAATCAG-3; Smn sense: 5-TGGGATGACTCCTTGCTGGT-3 and antisense: 5-GAGCAACACCTCCTGCTCGT-3; Rp49/RpL32 sense: 5-CGACGCTTCAAGGGACAGTATC-3 and antisense: 5-TCCGACCAG-GTTACAAGAACTCTC-3.
Quantitative PCR TaqMan gene expression assays (Applied Biosystems) were used to assess the expression of Smn (Dm01822923_s1) and heartless (Dm02373745_s1). The ribosomal protein gene Rp49/RpL32 (Dm02151827_g1) was used as a calibrator to normalize cDNA input. 6 ng of equivalent RNA was used for each reaction and samples were processed in triplicate. To determine relative gene expression levels, data were processed using the 2 -DDCt method (Livak and Schmittgen, 2001) normalized to the tub-GAL4 control sample. All calculations and plots were generated using Excel (Microsoft).
Online supplemental material Fig. S1 shows that Smn lethality is modified by mutations in the Drosophila FGF receptor breathless, and Smn knockdown alters levels of downstream targets of FGF pathway. Fig. S2 shows that postsynaptic expression of htl RNAi results in a loss of Htl protein localization. Fig. S3 shows bouton counts (non-normalized) of larval NMJs from genotypes depicted in Figs. 3 G, 5 G, and 6 G. Fig. S4 shows expansion of the NMJ in animals overexpressing Stumps by how24BGAL4. Fig. S5 shows reduction of Stumps staining in how24BGAL4/UAS Smn RNAi. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201004016/DC1.
